International Celiac Disease Symposium

描述(由申请人提供)： 美国国立卫生研究院关于乳糜泻的共识发展会议(2004年6月)得出结论，乳糜泻发生在大约1%的美国人口中，尽管到目前为止大多数人都没有被诊断出来。乳糜泻是一种独特的自身免疫性疾病，由于基因决定的对面筋的免疫不耐受，面筋是小麦和类似谷物的储存蛋白质的术语。目前唯一的治疗方法是无麸质饮食。纽约哥伦比亚大学的腹腔疾病中心将于2006年11月主办第十二届腹腔疾病国际研讨会。这项一年两次的活动是来自世界各地的临床医生和研究人员聚会的论坛，介绍当前的研究并交流关于这种疾病的知识。没有协会为这项活动提供资金。每个国家的个人组织者都会获得资金。最近的美国国立卫生研究院共识会议，再加上对乳糜泻的科学和临床兴趣的增加，以及对非饮食疗法开发的兴趣，使这次研讨会成为美国医疗、科学和制药行业的一项重要活动，在一个关键时刻举行。此外，发达国家和发展中国家对乳糜泻的诊断和治疗的兴趣都大大增加。我们组织了一次国际研讨会，来自世界各地的该领域的领导人参加了会议。此外，还将为患者、营养学家、医生助理、护士从业人员和医生设计一个临床论坛。我们预计这次会议的出席人数会很多。 在这份赠款申请中，我们介绍了这次国际研讨会的计划、会议的基本原理和预期结果。对于这次会议的成功来说，资金是至关重要的，这次会议将重塑美国和世界各地的乳糜泻的未来。

DESCRIPTION (provided by applicant): The NIH Consensus Development Conference on Celiac disease (June, 2004) concluded that celiac disease occurs in about 1% of the United States population, though by far the majority are undiagnosed. Celiac disease is a unique autoimmune disease due to a genetically determined immune intolerance to gluten, the term for the storage proteins of wheat and similar grains. The only current treatment is a gluten-free diet. The Celiac Disease Center at Columbia University in New York will host the XII International Symposium on Celiac Disease in November 2006. This biannual event is the forum in which clinicians and investigators from around the globe meet to present current research and exchange knowledge about this disease. There is no Society to fund this event. The individual organizers in each country obtain funding. The recent NIH Consensus Conference, combined with an increase in scientific and clinical interest in celiac disease and an interest in the development on non-dietary therapies makes this Symposium an important event for the medical, scientific and pharmaceutical industry in the United States, occurring at a crucial time. In addition there is a great increase in interest in the diagnosis and management of celiac disease in both the developed and the developing world. We have organized an International Symposium involving the leaders in the field from around the world. In addition there will be a Clinical Forum designed for patients, nutritionists, physician assistants, nurse practitioners and physicians. We anticipate a large turnout for this meeting. In this grant application we present the program, rationale for the meeting and the expected outcomes of this International Symposium. Funding is crucial for the success of this meeting that will reshape the future of celiac disease both in this country and around the world.